Related Experiment Video
Updated: Aug 10, 2026

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts
P D Stein1, J E Dalen, S Goldman
1Henry Ford Health System, Cardiac Wellness Center, Detroit, MI 48202-3006, USA. pstein1@hfhs.org
Insights
Aspirin effectively reduces saphenous vein bypass graft occlusion for one year when initiated perioperatively. However, extended aspirin use beyond one year offers no additional graft patency benefits.
Area of Science:
- Cardiovascular Surgery
- Pharmacology
- Thrombosis Research
Background:
- Saphenous vein graft (SVG) occlusion is a significant complication after coronary artery bypass grafting (CABG).
- Preventing SVG occlusion is crucial for long-term graft patency and patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of aspirin and other antithrombotic agents in preventing saphenous vein bypass graft occlusion.
- To assess the impact of timing and duration of aspirin therapy on graft patency and bleeding complications.
Main Methods:
- Systematic review and analysis of clinical trials investigating antithrombotic agents for SVG patency.
- Comparison of aspirin (various doses and timings), aspirin plus dipyridamole, ticlopidine, and oral anticoagulants against placebo or control groups.
Main Results:
- Aspirin (325-900 mg/d) initiated preoperatively or on the day of surgery effectively reduced SVG occlusion for one year.
- Aspirin combined with dipyridamole showed no added benefit over aspirin alone.
- Increased bleeding risk was observed with aspirin initiation one day before surgery.
- Ticlopidine demonstrated efficacy in maintaining graft patency when started postoperatively.
- Oral anticoagulants yielded inconsistent results for SVG patency maintenance.
- Extended aspirin use beyond one year did not provide additional long-term graft patency benefits.
Conclusions:
- Perioperative aspirin initiation is effective in reducing short-term saphenous vein bypass graft occlusion.
- Long-term aspirin therapy beyond one year does not enhance graft patency.
- Bleeding risk should be considered when timing aspirin initiation.
- Ticlopidine may be an alternative for maintaining graft patency, while oral anticoagulants show limited efficacy.
Abstract:
Aspirin (325 and 900 mg/d) is effective for a period of 1 year in reducing the frequency of saphenous vein bypass graft occlusion when begun 1 day before operation or on the day of operation. Aspirin in combination with dipyridamole is not more effective than aspirin alone in the prevention of saphenous vein graft occlusion. Bleeding is higher among patients treated with aspirin (325 mg/d) than among controls if aspirin is started 1 day before operation. Bleeding in one trial was greater than controls if aspirin (300 mg/d) was started the day of operation, and in one trial there was no difference when aspirin (325 mg/d) was started the day of operation. Ticlopidine (500 mg/d), started 2 days after operation, was effective in maintaining graft patency. Oral anticoagulants were inconsistent in the maintenance of saphenous vein graft patency. The continued use of aspirin for 2 additional years after an initial year of aspirin therapy for the prevention of saphenous vein bypass graft occlusion showed no additional long-term benefit on graft patency at the end of the third year. Antithrombotic agents given to patients with internal mammary artery bypass grafts showed no benefit in comparison to placebo because patency on placebo was high.
More Related Videos
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management